Carol Cherkis is the President of BioInfoStrategies, a global healthcare business consulting firm she founded after a multi-functional career with the Dow Chemical Company, where her last role was Biotechnology Program Director in the Corporate Ventures Group. From 2004 until 2019 she served as the life sciences expert for NewCap Partners, Inc., a private middle-market banking firm with offices in Southern and Northern California, where she helped the firm’s clients identify partner companies for M&A, strategic alliances, and corporate equity investments.
At BioInfoStrategies Carol’s diverse worldwide client base includes government agencies, startups, established middle-market companies, and Fortune 100 firms. Her expertise includes: strategic alliance formation, business development, competitive intelligence and strategic planning, organizational development, technology assessment and licensing, project management, and product development. Carol has a PhD in Biological Chemistry from the University of Michigan Medical School and an AB in Biology from Bryn Mawr College.